Scholarlink

Background and aims <p>Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Non-vitamin-K oral anticoagulants (NOACs) effectively reduce LAA thrombus prevalence and stroke risk. However, the optimal treatment of a NOAC-resistant thrombus remains unclear.&#xa0;We aimed to evaluate therapeutic strategies for resolving LAA thrombus in patients on optimal NOAC therapy. </p> Methods <p>We retrospectively analyzed patients scheduled for cardioversion or catheter ablation of AF between 2014 and 2023 with LAA thrombus on transesophageal echocardiography (TEE) despite being on optimal NOAC therapy. We assessed how the applied&#xa0;management strategy&#xa0;affected thrombus resolution.</p> Results <p>Among the&#xa0;analyzed 120 patients, a&#xa0;change to a different NOAC occurred in 41% of cases, a transition to a VKA in 30%, and the supplementation with antiplatelet therapy in 11%. In contrast, 18% of the patients received unchanged therapy. Follow-up imaging&#xa0;at&#xa0;65 [44 – 95] days showed successful thrombus resolution in 92 (77%) of cases,&#xa0;predicted by a lower CHA2DS2-VASc score (<i>p</i> = 0.01). Any modification of antithrombotic therapy&#xa0;was an independent predictor of thrombus resolution (OR 5.28 [1.55–18], <i>p</i> = 0.01). Of the four strategies, there was a trend toward better thrombus resolution with switching to a VKA (OR 3.23 [1.03–10.1], <i>p</i> = 0.04).</p> Conclusion <p>Resolution of LAA thrombus in patients already on adequate NOAC treatment may require a revision of&#xa0;the anticoagulation strategy. In addition, transitioning&#xa0;from NOAC to VKA might be considered. </p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月6日

查看全文
  • Ferenc Komlósi,
  • Bence Arnóth,
  • Imre Szakál,
  • Patrik Tóth,
  • Henriette Mészáros,
  • Helga Sánta,
  • Gyula Bohus,
  • Péter Vámosi,
  • Elektra Bartha,
  • Márton Horváth,
  • Melinda Boussoussou,
  • Nándor Szegedi,
  • Zoltán Salló,
  • István Osztheimer,
  • Péter Perge,
  • Gábor Széplaki,
  • László Gellér,
  • Béla Merkely,
  • Klaudia Vivien Nagy

摘要

Background and aims

Left atrial appendage (LAA) thrombus is the primary cause of stroke and systemic embolism in atrial fibrillation (AF). Non-vitamin-K oral anticoagulants (NOACs) effectively reduce LAA thrombus prevalence and stroke risk. However, the optimal treatment of a NOAC-resistant thrombus remains unclear. We aimed to evaluate therapeutic strategies for resolving LAA thrombus in patients on optimal NOAC therapy.

Methods

We retrospectively analyzed patients scheduled for cardioversion or catheter ablation of AF between 2014 and 2023 with LAA thrombus on transesophageal echocardiography (TEE) despite being on optimal NOAC therapy. We assessed how the applied management strategy affected thrombus resolution.

Results

Among the analyzed 120 patients, a change to a different NOAC occurred in 41% of cases, a transition to a VKA in 30%, and the supplementation with antiplatelet therapy in 11%. In contrast, 18% of the patients received unchanged therapy. Follow-up imaging at 65 [44 – 95] days showed successful thrombus resolution in 92 (77%) of cases, predicted by a lower CHA2DS2-VASc score (p = 0.01). Any modification of antithrombotic therapy was an independent predictor of thrombus resolution (OR 5.28 [1.55–18], p = 0.01). Of the four strategies, there was a trend toward better thrombus resolution with switching to a VKA (OR 3.23 [1.03–10.1], p = 0.04).

Conclusion

Resolution of LAA thrombus in patients already on adequate NOAC treatment may require a revision of the anticoagulation strategy. In addition, transitioning from NOAC to VKA might be considered.

Graphical abstract